CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shineco Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shineco Inc
T1, South Tower, Jiazhaoye Square
Phone: +86 1068329620p:+86 1068329620 BEIJING, BEJ  100022  China Ticker: SISISISI
Business Summary
Shineco Inc is a holding company. The Company provides health and well-being focused plant-based products by using its subsidiaries' and variable interest entities' vertically and horizontally integrated production, distribution and sales channels. The Company operates through three segments. Developing, producing and distributing innovative rapid diagnostic products and related medical devices for the most common diseases (Rapid Diagnostic and Other Products) :This segment is conducted through Biowin, which specializes in the development, production and distribution of innovative rapid diagnostic products and related medical devices for the most common diseases; Producing, processing and distribution of agricultural products, such as silk and silk fabrics as well as fresh fruit s (Other agricultural products): This segment is conducted through Wintus, which specializes in producing, processing and distribution of agricultural products, such as silk and silk fabrics as well as tra

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20236/30/2023YesYes---

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
3841 Surgical and medical instruments and apparatus
2033 Canned fruits, vegetables, preserves, jams, and jellies
2281 Yarn spinning mills

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board MikeZhao 59 3/25/2022 7/14/2021
Executive President XiaohuiWang 67 11/13/2023 11/13/2023
Chief Executive Officer, Director JenniferZhan 35 7/15/2021 7/14/2021
6 additional Officers and Directors records available in full report.

Business Names
Business Name
Ankang Longevity Pharmaceutical (Group) Co., Ltd.
Ankang Longevity Pharmaceutical (Group) Traditional Chinese Medicine Decoction Pieces Co., Ltd.
Ankang Longevity Pharmaceutical Group Chain Co., Ltd.
25 additional Business Names available in full report.

General Information
Number of Employees: 87 (As of 6/30/2023)
Outstanding Shares: 6,412,902 (As of 2/16/2024)
Shareholders: 178
Stock Exchange: NASD
Federal Tax Id: 522175898
Fax Number: (302) 266-9940


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 18, 2024